4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-035364
President and CEO sold 14,000 shares at an average $35.65 ($499,096)
- President and CEO acquired 14,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Mack David Henry · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-20 | Exercise or conversion : show line 1 in the form | +7,793 | $0.53 | $4,130 | 10,263 | D |
| 2021-05-20 | Sale : show line 2 in the form | −7,793 | $35.60 | $277,455 | 2,470 | D |
| 2021-05-21 | Exercise or conversion : show line 3 in the form | +6,207 | $0.53 | $3,290 | 8,677 | D |
| 2021-05-21 | Sale : show line 4 in the form | −6,207 | $35.71 | $221,641 | 2,470 | D |
| Open-market sales · 14,000 sh · avg $35.65 · $499,096 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-20 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −7,793 | 492,867 | D |
| 2021-05-21 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −6,207 | 485,074 | D |
Loading xslF345X03/doc4.xml…